Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 4.9 Exhibit 4.9
- 5.1 Exhibit 5.1
- 8.2 Exhibit 8.2
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 10.31 Exhibit 10.31
- 10.32 Exhibit 10.32
- 10.33 Exhibit 10.33
- 10.34 Exhibit 10.34
- 10.35 Exhibit 10.35
- 10.36 Exhibit 10.36
- 10.37 Exhibit 10.37
- 10.39 Exhibit 10.39
- 10.40 Exhibit 10.40
- 10.41 Exhibit 10.41
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.5 Exhibit 23.5
- 99.1 Exhibit 99.1
- 99.5 Exhibit 99.5
- 99.6 Exhibit 99.6
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- 99.10 Exhibit 99.10
- Download Excel data file
- View Excel data file
Associated filings
- 5 Oct 20 EFFECT Notice of effectiveness
- 2 Oct 20 424B3 Prospectus supplement
- 30 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Aug 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
6 Jul 20 S-4 Registration of securities issued in business combination transactions
OCUP similar filings
- 30 Sep 20 Registration of securities issued in business combination transactions (amended)
- 15 Sep 20 Registration of securities issued in business combination transactions (amended)
- 27 Aug 20 Registration of securities issued in business combination transactions (amended)
- 6 Jul 20 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.5
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated July 1, 2020, with respect to the financial statements of Ocuphire Pharma, Inc. included in the Registration Statement (Form S-4) and related prospectus of Rexahn Pharmaceuticals, Inc.
/s/ Ernst & Young LLP
Detroit, Michigan
July 6, 2020